AUDIT MicroControls, Inc. Announces Linearity FD Lipoprotein (a) 

Date: November 4, 2025

 

November 4, 2025 (Eatonton, GA) - AUDIT MicroControls, Inc. is pleased to announce the following new addition to our line of calibration verification/linearity and daily quality control products: Linearity FD Lipoprotein (a). This product is intended to simulate human patient samples for use in determining linearity, calibration verification and verification of reportable range for Lipoprotein (a).

The Linearity FD Lipoprotein (a), Order Number K743M-5, is for In Vitro Diagnostic use only. The Linearity FD Lipoprotein (a) is an IVD device consisting of 5 levels of freeze dried material. This product has an open vial stability of up to 5 days when stored at 2-8°C. 

AUDIT MicroControls provides Auditor QC, a free online, real-time data reduction program that offers Levey-Jennings charts and peer group analysis for daily quality control product users, as well as linearity graphs and peer group analysis. Report results are given immediately in an “inspector friendly format” and stored on the Auditor QC website for future reference.

 

AUDIT is the only total solution in linearity/calibration verification and daily quality control materials for clinical laboratories. We provide value to customers through high-quality products, easy-to-use data management tools, and unrivaled personalized service. Our partnership with Aalto Scientific, a leader in manufacturing and supply for more than forty years, enables us to offer significant cost-savings. This synergistic partnership means our customers benefit from a broad line of superior solutions that address the challenges faced by today’s labs. By better understanding our customers’ needs, AUDIT can find ways to make life in the lab a little easier.

 

For more information about AUDIT, please call (866) 25-AUDIT or visit www.auditmicro.com. To connect via social media, please visit facebook.com/AuditMicroControls, twitter.com/AUDITmicro, and linkedin.com/company/audit-microcontrols-inc.